Clinical Trial Update: Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation [Phase 2, Phase 3]

View source ↗

Summary

The document notes the completion of Phase 2 and Phase 3 clinical trials evaluating Anascorp for scorpion sting envenomation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Scorpion Sting Envenomation

Drugs mentioned

• Anascorp

Snippet

Sponsor: Instituto Bioclon S.A. de C.V. | Conditions: Scorpion Sting Envenomation | Phase 2, Phase 3 | Status: COMPLETED